Michael Klichinsky, Chief Scientific Officer at Carisma Therapeutics Inc. (CARM), sold 56,982 shares at $0.25 ($14K) on 2025-10-07, disclosed to the SEC on 2025-10-08.
Open-market sale of $14k CARM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.